Biznesradar bez reklam? Sprawdź BR Plus

Branża Biotechnologia

Stopy zwrotu

Profil 1t 1m 3m 6m YTD 12m 24m 36m 60m 120m
GEN (GENOMED) -2,49% +8,29% +42,03% +54,84% +70,20% +42,03% +48,16% +19,73% +10,72% +149,20%
GX1 (GENXONE) -3,11% +8,11% +0,72% -11,67% +40,35% +3,32% -31,37% -20,00% -78,57% bd.
SNT (SYNEKTIK) -3,73% -4,06% -7,49% +16,52% +33,57% +46,31% +114,69% +583,04% +1 366,37% +2 383,38%
ONO (ONESANO) +1,15% +1,62% +50,52% +31,93% +11,17% -1,79% -20,36% -33,64% -59,82% +6,93%
URT (URTESTE) +0,23% +1,42% -2,50% -1,61% +10,00% +24,35% -54,07% -61,00% bd. bd.
SCS (STEMCELLS) -8,33% -12,00% -14,56% -7,95% +8,37% +10,00% +84,87% +25,71% -47,62% -72,50%
SCP (SCPFL) +0,61% +2,50% +10,42% -6,68% -3,52% -25,76% -20,17% -17,88% +29,32% bd.
GRZ (GREENZEB) -6,74% -4,26% -8,63% +20,00% -8,16% -7,69% -36,71% bd. bd. bd.
MOC (MOLECURE) -5,70% -20,00% +1,19% +6,05% -9,70% -21,16% -42,91% -65,79% -83,96% bd.
MDB (MEDICOBIO) -0,56% -5,85% -13,66% -26,25% -11,28% -44,16% -28,92% -68,53% -84,94% -40,00%
RDG (READGENE) -2,42% -4,72% -0,82% -7,28% -11,36% -19,06% +0,83% +44,91% +89,80% +198,77%
NNG (NANOGROUP) -3,77% -7,82% -7,82% -9,45% -13,21% -7,82% -35,75% +141,09% -54,00% bd.
PTG (POLTREG) +2,81% 0,00% -12,61% +18,58% -17,96% -25,28% -61,35% -66,16% bd. bd.
BCX (BIOCELTIX) -2,01% -16,58% -32,91% -26,02% -18,30% -36,47% -17,66% -3,94% bd. bd.
BMX (BIOMAXIMA) -1,11% -2,57% -2,96% -15,32% -18,34% -25,45% -30,46% -42,79% -57,16% +113,79%
CTX (CAPTORTX) +0,18% -18,78% -22,84% -28,62% -20,69% +31,26% -16,76% -47,61% -71,01% bd.
GMT (GENOMTEC) -0,69% -18,53% -33,79% -40,86% -24,21% -51,92% -66,39% -77,67% -72,98% bd.
SNG (SYNERGA) +3,57% -3,79% -3,33% -9,78% -26,18% -51,08% -23,40% -56,72% -80,20% +103,00%
RVU (RYVU) -1,88% +11,74% +17,06% -24,68% -34,69% -28,77% -63,88% -72,98% -69,22% -7,12%
SLV (SELVITA) -6,46% -17,69% -27,09% -47,09% -57,13% -49,54% -67,22% -70,23% -76,56% bd.
MQR (MULTIQURE) -1,98% -4,00% -31,11% -40,95% -58,23% -66,59% -80,69% -72,29% -96,07% bd.
S2B (SYN2BIO) -6,79% -12,32% -11,67% +69,37% bd. bd. bd. bd. bd. bd.
Biznesradar bez reklam? Sprawdź BR Plus